BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16556171)

  • 1. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).
    Sallam H; McNearney TA; Chen JD
    Aliment Pharmacol Ther; 2006 Mar; 23(6):691-712. PubMed ID: 16556171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis.
    Sallam HS; McNearney TA; Chen JD
    Explore (NY); 2014; 10(1):44-52. PubMed ID: 24439095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in upper gastrointestinal motility during scleroderma].
    Bassotti G; Betti C; Pelli MA; Morelli A
    Medicina (Firenze); 1990; 10(3):251-5. PubMed ID: 2079874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Sclerosis: Gastrointestinal Disease and Its Management.
    Gyger G; Baron M
    Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.
    Greydanus MP; Camilleri M
    Gastroenterology; 1989 Jan; 96(1):110-5. PubMed ID: 2909417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal and small intestinal manifestations of progressive systemic sclerosis. A clinical and experimental study.
    Hendel L
    Dan Med Bull; 1994 Sep; 41(4):371-85. PubMed ID: 7813247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.
    Weston S; Thumshirn M; Wiste J; Camilleri M
    Am J Gastroenterol; 1998 Jul; 93(7):1085-9. PubMed ID: 9672335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal motility disorder assessment in systemic sclerosis.
    Savarino E; Mei F; Parodi A; Ghio M; Furnari M; Gentile A; Berdini M; Di Sario A; Bendia E; Bonazzi P; Scarpellini E; Laterza L; Savarino V; Gasbarrini A
    Rheumatology (Oxford); 2013 Jun; 52(6):1095-100. PubMed ID: 23382360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal dysmotility: evidence and clinical management.
    Chapman MJ; Nguyen NQ; Deane AM
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):209-16. PubMed ID: 23334174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis?
    Pakozdi A; Wilson H; Black CM; Denton CP
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):5-8. PubMed ID: 19796554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal involvement in systemic sclerosis: diagnosis and management.
    McMahan ZH; Hummers LK
    Curr Opin Rheumatol; 2018 Nov; 30(6):533-540. PubMed ID: 30234725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal manometry in patients with systemic sclerosis.
    Sjölund K; Bartosik I; Lindberg G; Scheja A; Wildt M; Akesson A
    Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1205-12. PubMed ID: 16215433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal manifestations of systemic sclerosis.
    Abu-Shakra M; Guillemin F; Lee P
    Semin Arthritis Rheum; 1994 Aug; 24(1):29-39. PubMed ID: 7985035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of gastric emptying half time as a quantitative measure of gastrointestinal dysmotility in systemic sclerosis.
    Adarsh MB; Bhattacharya A; Sharma SK; Dhir V; Sinha SK
    Rheumatology (Oxford); 2019 Nov; 58(11):2064-2065. PubMed ID: 31211395
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis.
    Ahuja NK; Mische L; Clarke JO; Wigley FM; McMahan ZH
    Semin Arthritis Rheum; 2018 Aug; 48(1):111-116. PubMed ID: 29397195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrition in systemic sclerosis.
    Recasens MA; Puig C; Ortiz-Santamaria V
    Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Dysmotility in Critically Ill Children: Pathophysiology, Diagnosis, and Management.
    Martinez EE; Douglas K; Nurko S; Mehta NM
    Pediatr Crit Care Med; 2015 Nov; 16(9):828-36. PubMed ID: 26218259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.
    Di Ciaula A; Covelli M; Berardino M; Wang DQ; Lapadula G; Palasciano G; Portincasa P
    BMC Gastroenterol; 2008 Feb; 8():7. PubMed ID: 18304354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.